Carisma
0 followers
CARM
Performance
About Carisma
Carisma is a biotechnology company pioneering CAR-Macrophages and CAR-Monocytes for solid tumor immunotherapy, with applications in fibrosis, oncology, and autoimmune disorders. The company focuses on engineering macrophages to modulate the tumor microenvironment and enhance anti-tumor activity. Their work centers on macrophage- and monocyte-based cell therapies aimed at solid tumors, with broader implications for fibrotic and autoimmune diseases.
Recent News
No recent news for this company.
Recent Deals
No recent deals for this company.
